Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;67(4):1287-1294.
doi: 10.1007/s10620-021-06947-x. Epub 2021 Mar 23.

Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease

Grant E Barber  1 , Steven Hendler  2 , Monica Choe  3 , Kian Keyashian  3 , Sarah Lechner  3 , Berkeley N Limketkai  4 , David Limsui  3
Affiliations

Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease

Grant E Barber et al. Dig Dis Sci. 2022 Apr.

Abstract

Background: Crohn's disease (CD) and ulcerative colitis (UC) are complex, inflammatory bowel diseases (IBD) with debilitating complications. While severe IBD typically requires biologic agents, the optimal therapy for mild-moderate IBD is less clear.

Aims: To assess the efficacy of thiopurine monotherapy for maintenance of mild-moderate IBD and clinical variables associated with treatment outcome.

Methods: This retrospective study included adults with mild-moderate IBD who were started on thiopurines without biologic therapy. The primary outcome was therapy failure, defined by disease progression based on clinical, endoscopic, and radiologic criteria. Clinical variables were extracted at time of thiopurine initiation. Univariable and multivariable Cox proportional hazards models were used to examine the independent contribution of the clinical variables on treatment response.

Results: From 230 CD patients, 64 (72%) were free of treatment failure with mean follow-up of 3.3 years. In our multivariable model, thiopurine failure was associated with concomitant systemic steroid administration (aHR 2.43, p = 0.001), whereas protective factors included concomitant oral 5-aminosalicylic acid (5-ASA) therapy (aHR 0.54, p = 0.02) and non-fistulizing, non-stricturing disease (aHR 0.57, p = 0.047). From 173 UC patients, 50 (71%) were free from treatment failure with mean follow-up of 3.3 years. On multivariable analysis, concomitant oral steroids were associated with thiopurine failure (aHR 2.71, p = 0.001). Only 13 (4%) discontinued thiopurines from adverse effects.

Conclusions: In mild-moderate uncomplicated IBD, thiopurine monotherapy was associated with longitudinal maintenance of remission and may represent a lower-cost, convenient, and effective alternative to biologics. Multiple clinical variables were predictive of treatment response.

Keywords: Crohn’s disease; Inflammatory bowel disease; Thiopurines; Ulcerative colitis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Cosnes J et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785–1794 - DOI
    1. Cosnes J, Seksik P. Inflammatory bowel disease: from sulfasalazine to biologics. Gastroenterol Clin Biol 2009;33:692–701 - DOI
    1. Present DH et al. Treatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981–987 - DOI
    1. Brocteur J, Moens C. Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study. Acta Rheumatol Scand 1965;11:221–230 - DOI
    1. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014;20:91–99 - DOI

LinkOut - more resources